CD10 expression is enhanced by Twist1 and associated with poor prognosis in esophageal squamous cell carcinoma with facilitating tumorigenicity in vitro and in vivo

International Journal of Cancer

Volumn 136, Issue 2, 2015, Pages 310-321

  Lee, Keun Woo ^a,b   Sung, Chang Ohk ^c   Kim, Jeong Hoon ^b,d   Kang, Myungsoo ^b,d   Yoo, Hae Yong ^b,d   Kim, Hyeon Ho ^b,d   Um, Sung Hee ^a   Kim, Seok Hyung ^a,b  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b Sungkyunkwan University   (South Korea)

^c University of Ulsan College of Medicine   (South Korea)

^d Samsung Medical Center   (South Korea)

Author keywords

carcinoma; CD10; esophagus; MME; prognosis; stromal cell; Twist1

Indexed keywords

COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; MESSENGER RNA; PROTEIN CAGGTG; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR TWIST1; TUMOR PROTEIN; UNCLASSIFIED DRUG; MEMBRANE METALLOENDOPEPTIDASE; NUCLEAR PROTEIN; TRANSCRIPTION FACTOR TWIST; TWIST1 PROTEIN, HUMAN;

AGED; ANCHORAGE INDEPENDENT GROWTH; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING SITE; CANCER INHIBITION; CANCER PROGNOSIS; CARCINOGENICITY; CD10 GENE; CELL INVASION; CELL MIGRATION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE FREE SURVIVAL; ESOPHAGEAL CANCER CELL LINE; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FEMALE; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; OVERALL SURVIVAL; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA CELL LINE; STROMA CELL; TRANSCRIPTION INITIATION; TUMOR GENE; UPREGULATION; XENOGRAFT; ANIMAL; APOPTOSIS; BAGG ALBINO MOUSE; CANCER STAGING; CELL ADHESION; CELL MOTION; CELL PROLIFERATION; CHROMATIN IMMUNOPRECIPITATION; DRUG SCREENING; ENZYME IMMUNOASSAY; ESOPHAGUS TUMOR; FIBROBLAST; FLOW CYTOMETRY; GENETICS; METABOLISM; MORTALITY; NUDE MOUSE; PATHOLOGY; PROGNOSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SITE DIRECTED MUTAGENESIS; SQUAMOUS CELL CARCINOMA; SURVIVAL RATE; TUMOR CELL CULTURE; WESTERN BLOTTING;

AGED; ANIMALS; APOPTOSIS; BLOTTING, WESTERN; CARCINOMA, SQUAMOUS CELL; CELL ADHESION; CELL MOVEMENT; CELL PROLIFERATION; CHROMATIN IMMUNOPRECIPITATION; ESOPHAGEAL NEOPLASMS; FEMALE; FIBROBLASTS; FLOW CYTOMETRY; HUMANS; IMMUNOENZYME TECHNIQUES; IN VITRO TECHNIQUES; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; MUTAGENESIS, SITE-DIRECTED; NEOPLASM STAGING; NEPRILYSIN; NUCLEAR PROTEINS; PROGNOSIS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; STROMAL CELLS; SURVIVAL RATE; TUMOR CELLS, CULTURED; TWIST TRANSCRIPTION FACTOR; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84921907685     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.29006     Document Type: Article

References (34)

1. Bachelard-Cascales E, Chapellier M, Delay E, et al., The CD10 enzyme is a key player to identify and regulate human mammary stem cells. Stem Cells 2010; 28: 1081-8.
2. Roques BP, Noble F, Dauge V, et al., Neutral endopeptidase 24.11: structure, inhibition, and experimental and clinical pharmacology. Pharmacol Rev 1993; 45: 87-146.
3. Turner AJ, Tanzawa K,. Mammalian membrane metallopeptidases: NEP, ECE, KELL, and PEX. FASEB J 1997; 11: 355-64.
4. Moreau I, Duvert V, Caux C, et al., Myofibroblastic stromal cells isolated from human bone marrow induce the proliferation of both early myeloid and B-lymphoid cells. Blood 1993; 82: 2396-405.
5. Erdos EG, Skidgel RA,. Neutral endopeptidase 24.11 (enkephalinase) and related regulators of peptide hormones. FASEB J 1989; 3: 145-51.
6. Chu P, Arber DA,. Paraffin-section detection of CD10 in 505 nonhematopoietic neoplasms. Frequent expression in renal cell carcinoma and endometrial stromal sarcoma. Am J Clin Pathol 2000; 113: 374-82.
7. Fleischmann A, Schlomm T, Huland H, et al., Distinct subcellular expression patterns of neutral endopeptidase (CD10) in prostate cancer predict diverging clinical courses in surgically treated patients. Clin Cancer Res 2008; 14: 7838-42.
8. Huang WB, Zhou XJ, Chen JY, et al., CD10-positive stromal cells in gastric carcinoma: correlation with invasion and metastasis. Jpn J Clin Oncol 2005; 35: 245-50.
9. Iwaya K, Ogawa H, Izumi M, et al., Stromal expression of CD10 in invasive breast carcinoma: a new predictor of clinical outcome. Virchows Arch 2002; 440: 589-93.
10. Makretsov NA, Hayes M, Carter BA, et al., Stromal CD10 expression in invasive breast carcinoma correlates with poor prognosis, estrogen receptor negativity, and high grade. Mod Pathol 2007; 20: 84-9.
11. Nishihara Y, Aishima S, Hayashi A, et al., CD10+ fibroblasts are more involved in the progression of hilar/extrahepatic cholangiocarcinoma than of peripheral intrahepatic cholangiocarcinoma. Histopathology 2009; 55: 423-31.
12. Ogawa H, Iwaya K, Izumi M, et al., Expression of CD10 by stromal cells during colorectal tumor development. Hum Pathol 2002; 33: 806-11.
13. Bilalovic N, Sandstad B, Golouh R, et al., CD10 protein expression in tumor and stromal cells of malignant melanoma is associated with tumor progression. Mod Pathol 2004; 17: 1251-8.
14. Oba J, Nakahara T, Hayashida S, et al., Expression of CD10 predicts tumor progression and unfavorable prognosis in malignant melanoma. J Am Acad Dermatol 2011; 65: 1152-60.
15. Velazquez EF, Yancovitz M, Pavlick A, et al., Clinical relevance of neutral endopeptidase (NEP/CD10) in melanoma. J Transl Med 2007; 5: 2.
16. Dall'Era MA, True LD, Siegel AF, et al., Differential expression of CD10 in prostate cancer and its clinical implication. BMC Urol 2007; 7: 3.
17. Lee MS, Lowe GN, Strong DD, et al., TWIST, a basic helix-loop-helix transcription factor, can regulate the human osteogenic lineage. J Cell Biochem 1999; 75: 566-77.
18. Yang J, Mani SA, Donaher JL, et al., Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell 2004; 117: 927-39.
19. Lee KW, Kim JH, Han S, et al., Twist1 is an independent prognostic factor of esophageal squamous cell carcinoma and associated with its epithelial-mesenchymal transition. Ann Surg Oncol 2012; 19: 326-35.
20. Sung CO, Lee KW, Han S, et al., Twist1 is up-regulated in gastric cancer-associated fibroblasts with poor clinical outcomes. Am J Pathol 2011; 179: 1827-38.
21. Sung CO, Park CK, Kim SH,. Classification of epithelial-mesenchymal transition phenotypes in esophageal squamous cell carcinoma is strongly associated with patient prognosis. Mod Pathol 2011; 24: 1060-8.
22. Sung CO, Han SY, Kim SH,. Low expression of claudin-4 is associated with poor prognosis in esophageal squamous cell carcinoma. Ann Surg Oncol 2011; 18: 273-81.
23. Cerami E, Gao J, Dogrusoz U, et al., The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov 2012; 2: 401-4.
24. Gao J, Aksoy BA, Dogrusoz U, et al., Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal 2013; 6: pl1.
25. Barretina J, Caponigro G, Stransky N, et al., The cancer cell line encyclopedia enables predictive modelling of anticancer drug sensitivity. Nature 2012; 483: 603-7.
26. Eckert MA, Lwin TM, Chang AT, et al., Twist1-induced invadopodia formation promotes tumor metastasis. Cancer Cell 2011; 19: 372-86.
27. Ikenaga N, Ohuchida K, Mizumoto K, et al., CD10+ pancreatic stellate cells enhance the progression of pancreatic cancer. Gastroenterology 2010; 139: 1041-51, 51 e1-8.
28. Piattelli A, Fioroni M, Iezzi G, et al., CD10 expression in stromal cells of oral cavity squamous cell carcinoma: a clinic and pathologic correlation. Oral Dis 2006; 12: 301-4.
29. Cui L, Ohuchida K, Mizumoto K, et al., Prospectively isolated cancer-associated CD10(+) fibroblasts have stronger interactions with CD133(+) colon cancer cells than with CD133(-) cancer cells. PLoS One 2010; 5: e12121.
30. Nanus DM,. Of peptides and peptidases: the role of cell surface peptidases in cancer. Clin Cancer Res 2003; 9: 6307-9.
31. Maguer-Satta V, Besancon R, Bachelard-Cascales E,. Concise review: neutral endopeptidase (CD10): a multifaceted environment actor in stem cells, physiological mechanisms, and cancer. Stem Cells 2011; 29: 389-96.
32. Zheng R, Iwase A, Shen R, et al., Neuropeptide-stimulated cell migration in prostate cancer cells is mediated by RhoA kinase signaling and inhibited by neutral endopeptidase. Oncogene 2006; 25: 5942-52.
33. Galy A, Morel F, Hill B, et al., Hematopoietic progenitor cells of lymphocytes and dendritic cells. J Immunother 1998; 21: 132-41.
34. Sunday ME, Hua J, Torday JS, et al., CD10/neutral endopeptidase 24.11 in developing human fetal lung. Patterns of expression and modulation of peptide-mediated proliferation. J Clin Invest 1992; 90: 2517-25.